Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.66 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.58 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.55 |
| ▸ | DPP4 | P27487 | 1/20 | 0.55 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.51 |
| ▸ | SNCA | P37840 | 1/20 | 0.51 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28643734 | 0.86 | TUBB1 (0.55) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL30307376 | 0.86 | CYP1A2 (0.63) | MEN1KMT2AABCG2CYP1A2 | |
| SCHEMBL547153 | 0.86 | CYP1A2 (0.63) | MEN1KMT2AABCG2CYP1A2 | |
| SCHEMBL19655666 | 0.84 | SLC22A6 (0.68) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL20897645 | 0.83 | SLC22A6 (0.62) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| Vanillic Acid SCHEMBL26622368 | 0.83 | HTT (0.81) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL19632973 | 0.83 | ABCG2 (0.47) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| Apocynin SCHEMBL31510122 | 0.82 | HTT (0.63) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL4895137 | 0.81 | ALDH1A1 (0.49) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| Vanillic Acid SCHEMBL30638774 | 0.81 | HTT (0.83) | SLC22A6SLC22A8MEN1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117551325-A | PVC flame-retardant floor film and preparation method thereof | 镇江双晟新材料有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-120005686-A | Composition comprising lipase and sulfite | 诺维信公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-110651038-B | Composition comprising lipase and sulfite | 诺维信公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-118679196-A | Polymer stabilizer based on methoxy-hydroxy-benzoic acid, plastic composition, method for stabilizing a plastic composition and stabilizer composition | 弗劳恩霍夫应用研究促进协会 | 2024-09-20 | — | — | CN | disclosed |
| US-20240207454-A1 | NEURO-BEHAVIORAL ASSAY FOR PHYSIOLOGICAL EVALUATION OF WATER-SOLUBLE ANESTHETICS | NORTHEASTERN UNIVERSITY | 2024-06-27 | — | — | US | disclosed |
| CN-117551325-A | PVC flame-retardant floor film and preparation method thereof | 镇江双晟新材料有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-117304033-A | Caffeic acid derivative and preparation method thereof, pharmaceutical composition and application | 中国医学科学院药物研究所 | 2023-12-29 | — | — | CN | disclosed |
| CN-117069567-A | Method for converting oxidized lignin and model compound thereof into high-added-value organic small molecular compound | 兰州大学 | 2023-11-17 | — | — | CN | disclosed |
| CN-110713866-B | Liquid detergent composition for clothing | 花王株式会社 | 2022-05-03 | — | — | CN | disclosed |
| CN-108342258-B | Liquid detergent composition | 花王株式会社 | 2022-04-01 | — | — | CN | disclosed |
| WO-2013192091-A1 | COMPOUNDS WITH (1E, 6E)-1,7-BIS-(3,4-DIMETHOXYPHENYL)-4,4-DISSTITUTED-HEPA-1,6-DIENE-3,5-DIONE STRUCTURAL SCAFFOLD, THEIR BIOLOGICAL ACTIVITY, AND USES THEREOF | ANDROSCIENCE CORPORATION (US) | 2013-12-27 | — | — | WO | disclosed |
| US-20130338160-A1 | Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof | Annji Pharmaceutical Co., Ltd. (TW) | 2013-12-19 | — | — | US | disclosed |
| US-20130261121-A1 | Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof | Annji Pharmaceutical Co., Ltd. (TW) | 2013-10-03 | — | — | US | disclosed |
| US-8236852-B2 | Drugs/cosmetics having at least one (substituted phenyl)-propenal moiety; bioavailability' water solubility; antiandrogens; antiinflammatory and wound healing agents; antiarthritic agents; acne; alopecia, hirsutism; anticarcinogenic agents; cancer of the bladder, liver, breast; Kennedy's disease | ANDROSCIENCE CORPORATION (US) | 2012-08-07 | — | — | US | disclosed |
| US-8202905-B2 | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof | ANDROSCIENCE CORPORATION (US) | 2012-06-19 | — | — | US | disclosed |
| WO-2011003029-A2 | CATALYTIC DISPROPORTIONATION AND CATALYTIC REDUCTION OF CARBON-CARBON AND CARBON-OXYGEN BONDS OF LIGNIN AND OTHER ORGANIC SUBSTRATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-01-06 | — | — | WO | disclosed |
| US-20100292342-A1 | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof | Annji Pharmaceutical Co., Ltd. (TW) | 2010-11-18 | — | — | US | disclosed |
| EP-2104659-A1 | COMPOUNDS WITH (SUBSTITUTED PHENYL)-PROPENAL MOIETY, THEIR DERIVATIVES, BIOLOGICAL ACTIVITY, AND USES THEREOF | AndroScience Corporation (US) | 2009-09-30 | — | — | EP | disclosed |
| US-20080188557-A1 | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof | Annji Pharmaceutical Co., Ltd. (TW) | 2008-08-07 | — | — | US | disclosed |
| WO-2008085984-A1 | COMPOUNDS WITH (SUBSTITUTED PHENYL)-PROPENAL MOIETY, THEIR DERIVATIVES, BIOLOGICAL ACTIVITY, AND USES THEREOF | ANDROSCIENCE CORPORATION (US) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292342-A1 | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof | AR, CYP17A1, CYP19A1 | SLC22A6 4282/4885SLC22A8 4426/4885MEN1 2395/4885 |
| US-20130338160-A1 | Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof | AR, BRCA1, CYP17A1 | SLC22A6 4512/4885SLC22A8 4714/4885MEN1 2785/4885 |
| US-20080188557-A1 | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof | AR, CYP17A1, CYP19A1 | SLC22A6 4282/4885SLC22A8 4426/4885MEN1 2395/4885 |
| US-20130261121-A1 | Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof | AR, BRCA1, CYP17A1 | SLC22A6 4512/4885SLC22A8 4714/4885MEN1 2785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.